TY - JOUR
T1 - IL-17 promotes immune privilege of corneal allografts
AU - Cunnusamy, Khrishen
AU - Chen, Peter W.
AU - Niederkorn, Jerry Y.
PY - 2010/10/15
Y1 - 2010/10/15
N2 - Corneal allograft rejection has been described as a Th1-mediated process involving IFN-γ production. However, it has been reported that corneal allograft rejection soars in IFN-γ-/- mice or mice treated with anti-IFN-γ mAb. Th17 is a recently described IL-17A-producing Th cell population that has been linked to renal and cardiac graft rejection, which was originally thought to be Th1-mediated. We tested the hypothesis that Th17 cells mediate corneal allograft rejection in an IL-17A-dependent fashion and unexpectedly found that depletion of IL-17A increased the incidence of rejection to 90%. We demonstrate that the exacerbated rejection following depletion of IL-17A did not result from a loss of cross-regulation of Th1 cells or exaggerated delayed-type hypersensitivity responses. Instead, inhibition of the Th1 or Th17 cell lineages promoted the emergence of a Th2 cell subset that independently mediated allograft rejection. These findings demonstrate that IL-17A is not required for corneal allograft rejection and may instead contribute to the immune privilege of corneal allografts.
AB - Corneal allograft rejection has been described as a Th1-mediated process involving IFN-γ production. However, it has been reported that corneal allograft rejection soars in IFN-γ-/- mice or mice treated with anti-IFN-γ mAb. Th17 is a recently described IL-17A-producing Th cell population that has been linked to renal and cardiac graft rejection, which was originally thought to be Th1-mediated. We tested the hypothesis that Th17 cells mediate corneal allograft rejection in an IL-17A-dependent fashion and unexpectedly found that depletion of IL-17A increased the incidence of rejection to 90%. We demonstrate that the exacerbated rejection following depletion of IL-17A did not result from a loss of cross-regulation of Th1 cells or exaggerated delayed-type hypersensitivity responses. Instead, inhibition of the Th1 or Th17 cell lineages promoted the emergence of a Th2 cell subset that independently mediated allograft rejection. These findings demonstrate that IL-17A is not required for corneal allograft rejection and may instead contribute to the immune privilege of corneal allografts.
UR - http://www.scopus.com/inward/record.url?scp=78049508039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049508039&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1001576
DO - 10.4049/jimmunol.1001576
M3 - Article
C2 - 20844197
AN - SCOPUS:78049508039
SN - 0022-1767
VL - 185
SP - 4651
EP - 4658
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -